Skip to content
TrialScanner

NCT04708782

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

Phase 3CompletedUTHRLead

Registry record

Lead sponsor
United Therapeutics
Conditions
Idiopathic Pulmonary Fibrosis; Interstitial Lung Disease
Primary completion
Feb 2, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04708782 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04708782: Study of Efficacy and Safety... | TrialScanner